<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04991064</url>
  </required_header>
  <id_info>
    <org_study_id>38912240102212</org_study_id>
    <nct_id>NCT04991064</nct_id>
  </id_info>
  <brief_title>Retention of Maxillary Complete Dentures Modified With Titanium Dioxide Nanoparticles: A Randomized Crossover Clinical Trial.</brief_title>
  <official_title>Retention of Maxillary Complete Dentures Modified With Titanium Dioxide Nanoparticles: A Randomized Crossover Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigates the effect of the addition of titanium dioxide nanoparticles to&#xD;
      denture base materials on their retention compared to that of the unmodified denture base&#xD;
      materials.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All patients will be randomly allocated to two equal groups either with the protocol I or II&#xD;
      (5 in each group) with an allocation ratio of 1:1 through a computer-generated sequence by a&#xD;
      spreadsheet (Excel, Microsoft Office 2010; Microsoft Corp). The group with the protocol I&#xD;
      will use the modified dentures with titanium dioxide nanoparticles (TiO2NP) during the first&#xD;
      month, followed by no use of the first denture and the use of their old relined dentures&#xD;
      instead for 1 month (washout), and then the use of the unmodified dentures for 1 month; the&#xD;
      group with the protocol II will use the unmodified dentures during the first month, followed&#xD;
      by no use of the first denture and the use of their old relined dentures instead for 1 month&#xD;
      (washout), and then the use of the modified dentures TiO2NP for 1 month. Assessment of&#xD;
      retention will be done immediately and 1 month after denture insertion.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 12, 2017</start_date>
  <completion_date type="Actual">June 15, 2017</completion_date>
  <primary_completion_date type="Actual">June 3, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of the change in the retention within each type of complete denture.</measure>
    <time_frame>Assessment will be done Immediately and 1 month after denture insertion within each type of denture.</time_frame>
    <description>It is measured in Newton.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Denture Retention</condition>
  <condition>Complete Dentures</condition>
  <arm_group>
    <arm_group_label>AB arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>participants allocated to this arm receive treatment A first, followed by treatment B.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BA arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>participants allocated to this arm receive treatment B first, followed by treatment A.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Complete denture base modified by Titanium dioxide nanoparticles.</intervention_name>
    <description>Titanium dioxide nanoparticles will be mixed with resin powder of the denture base before mixing the powder and liquid of the heat cure denture base material.</description>
    <arm_group_label>AB arm</arm_group_label>
    <arm_group_label>BA arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients requiring new removable complete dentures, with class I edentulous arches&#xD;
             based on the American College of Prosthodontists (ACP) classification15, with an&#xD;
             average age of 45-55 years old, with healthy temporomandibular joint, being without&#xD;
             systemic disease that could affect the neuromuscular control or salivary flow&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with ACP Class II, III, or IV, and xerostomia.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Faculty of Oral and Dental Medicine</name>
      <address>
        <city>Cairo</city>
        <state>Manyal</state>
        <zip>12554</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 17, 2021</study_first_submitted>
  <study_first_submitted_qc>July 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 5, 2021</study_first_posted>
  <last_update_submitted>September 17, 2021</last_update_submitted>
  <last_update_submitted_qc>September 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Amr Gamal Ismail Mohamed</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Titanium dioxide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Only the co-author has the IPD. He is responsible to store it in an inaccessible place for anyone.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

